“…Studies have shown that miR-1301 is down-regulated in 11 cancers. These tumors include esophageal cancer ( 12 , 38 , 39 ), oral squamous cell carcinoma (OSCC) ( 13 ), colorectal cancer (CRC) ( 6 , 17 , 18 , 40 ), laryngeal squamous cell carcinoma (LSCC) ( 41 ), papillary thyroid carcinoma (PTC) ( 7 , 23 , 42 ), clear cell renal cell carcinoma (ccRCC) ( 27 ), bladder cancer ( 28 ), cervical cancer ( 33 ), glioma ( 4 , 24 , 29 ), osteosarcoma ( 8 , 9 , 43 ), and CML ( 10 ). In these tumors, miR-1301 is regulated by at least 12 ncRNAs, including 3 circRNAs (MYLK, circ_0004370 and circ_0067934) and 9 lncRNAs (LINC01433, MIAT, LINC01207, RNCR3, VPS9D1-AS1, ABHD11-AS1, SNHG16, NNT-AS1, PVT1).…”